Zenith™ is an amniotic membrane allograft derived from a prescreened mother with a planned delivery. Designed as a sterile, protective wound covering, it features a dehydrated extracellular matrix that serves as a scaffold to support native tissue. The membrane is minimally processed to preserve its native structure and is terminally sterilized to ensure safety throughout the treatment process. Confirmed by the FDA Tissue Reference Group to be regulated solely under Section 361 of the PHS Act, Zenith™ provides a reliable wound care solution backed by decades of science.